Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation [NA]

View source ↗

Summary

This update concerns a multicenter, randomized study of tegaserod 2 mg twice daily vs placebo for chronic constipation. The study was terminated and no efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Zelnorm (tegaserod)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Constipation, Chronic Disease | NA | Status: TERMINATED